|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
27 Number 27
30 September 2025
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
27, Year 2025 >
Number 27, 30 September
|
|
|
|
|
|
Rana A, Mittal A, Vashist C, Sharma S, Rajput S, Sridhar SB,
Malviya R.
Nanoparticle-Based
Approaches for Glioblastoma Treatment: Advances and Future
Prospects.
CNS
Neurol Disord Drug Targets. 2025 Sep 22. doi:
10.2174/0118715273386112250912172648. PMID:
40993928. Review˰
ˍ
|
|
|
|
Reitman ZJ, Fan Y.
Authors' View-FLASH
Radiation: A Game-Changer in Pediatric Brain Tumor Treatment?
Int
J Radiat Oncol Biol Phys. 2025 Sep 23;123(3):848-851.
doi:
10.1016/j.ijrobp.2025.04.036. PMID:
40998483. Editorial˰
ˍ
|
|
|
|
Bruno F, Pellerino A, Pronello E, Rudà R.
Rare
gliomas: standard treatment approaches and new target therapies.
Curr
Opin Neurol. 2025 Sep 25. doi:
10.1097/WCO.0000000000001428. PMID:
40990677. Review˰
ˍ
|
|
|
|
Jiang S, Zhong C.
Glioma drug
development benefits from emerging phase 0 and
window-of-opportunity trial paradigm.
Cell
Commun Signal. 2025 Sep 25;23(1):399. doi:
10.1186/s12964-025-02408-4. PMID:
40999453. Review. ˍ
|
|
|
|
Pan XH, Wang N, He YC, Su J, Gao YF.
Scientometric
analysis of glioblastoma and blood-brain barrier research
(1995-2024): evolving trends and therapeutic challenges.
Front
Oncol. 2025 Sep 25;15:1649414. doi:
10.3389/fonc.2025.1649414. PMID:
41079104. Bibliometric analysis. ˍ
|
|
|
|
Zhang C, Zhang H, Cao J, Liu M.
Neuroscience
in glioma biology (Review).
Oncol
Rep. 2025 Sep 25;54(6):166. doi:
10.3892/or.2025.8999. PMID:
40999988. Review. ˍ
|
|
|
|
Liu S, Liang R.
Oncolytic Virotherapy
for Glioma: A Bibliometric Roadmap for Multidisciplinary Clinical
and Research Strategies.
J
Multidiscip Healthc. 2025 Sep 26;18:6167-6185. doi:
10.2147/JMDH.S557248. PMID:
41040426. Bibliometric analysis. ˍ
|
|
|
|
Scarpitta R, Cappello E, Cangialosi A, Gori V, Luca G, Gori G,
Bocci G.
Pharmacological Phase I
Clinical Trials in Pediatric Brain Tumors (1990-2024): A
Historical Perspective.
Oncol
Res. 2025 Sep 26;33(10):2603-2656. doi:
10.32604/or.2025.066260. PMID:
41050069. Review.
ˍ
|
|
|
|
Li J, Lu L, Duan Y, Huang G, Fang X, Deng Y, Tang F, Jiang F, Dai
D.
Global research trends in CAR-T
cell therapy for glioblastoma: a bibliometric and visualized
analysis.
Discov
Oncol. 2025 Sep 29;16(1):1770. doi:
10.1007/s12672-025-03285-6. PMID:
41021151. Bibliometric analysis. ˍ
|
|
|
|
Yazgan SC, Yekedüz E, Akkuş E, Sun M, Gillessen S,
Fizazi K, McKay RR, Ay C, Castro E, Agarwal N, Choueiri TK, Ürün
Y. Venous thromboembolic event risk with
PARP inhibitors in solid tumors: a systematic review and
meta-analysis.
ESMO
Open. 2025 Sep 29;10(10):105811. doi:
10.1016/j.esmoop.2025.105811. PMID:
41027069. Review; Meta-analysis. ˍ
|
|
|
|
Schurr A.
Glioma neuron symbiosis: a
hypothesis.
Front
Neurosci. 2025 Sep 30;19:1646148. doi:
10.3389/fnins.2025.1646148. PMID:
41098857. Perspective. ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|